Published on
January 4, 2024
- 21:03 GMT
NeuroX1 Inc. and Everlum Bio Inc. Announce a Partnership to Develop Therapeutics for Rare Pediatric Diseases.
NeuroX1 Inc. and Everlum Bio Inc. Announce a Partnership to Develop Novel Small-Molecule Therapeutics for Rare and Neglected Pediatric Diseases. AUSTIN, TX, USA, January 4, 2024 /EINPresswire.com/ -- NeuroX1 Inc. and Everlum Bio Inc. have established a …
Distribution channels:
Business & Economy, Companies
...
